3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
5
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma of Lung
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Spinal Fractures
1
Smoking Cessation
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Phyllodes Tumor
1
Pancreatic Neoplasms
1
Osteoporosis
1
Nevus
1
Neoplastic Cells, Circulating
1
Multiple Pulmonary Nodules
1
Lymphoma, Follicular
1
Lung Diseases
1
Locally Advanced Pancreatic Cancer
1
Liver Cirrhosis
1
Inflammatory Bowel Diseases
1
Hypertension, Portal
1
Head and Neck Neoplasms
1
Interventions
Cyclophosphamide
176
Rituximab
164
fludarabine phosphate
97
Peripheral Blood Stem Cell Transplantation
95
Filgrastim
73
Etoposide
67
Radiotherapy
63
Mycophenolic Acid
62
Whole-Body Irradiation
58
Tacrolimus
49
Melphalan
49
Cyclosporine
49
Busulfan
47
Lenalidomide
45
Antilymphocyte Serum
39
Vincristine
37
Prednisone
37
Cytarabine
37
fludarabine
35
Methotrexate
33
Carmustine
32
obinutuzumab
31
Doxorubicin
30
Bendamustine Hydrochloride
30
Methylprednisolone
27
ibritumomab tiuxetan
25
Cord Blood Stem Cell Transplantation
25
sargramostim
24
Bortezomib
24
Granulocyte Colony-Stimulating Factor
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, Follicular
×
Diagnostic Imaging
×
Clear all
NCT01718730
2019-10-22
Cortical Excitability and Inhibition in MDD
Mayo Clinic
Completed
23 enrolled